DelSiTech Ltd Announces the Appointment of Dr. Hanna Arstila as the Director, Head of Formulation Development

DelSiTech Ltd Announces the Appointment of Dr. Hanna Arstila as the Director, Head of Formulation Development

2020-10-23T10:15:47+00:00 October 21st, 2020|

Dr. Hanna Arstila, Director, Head of Formulation Development

Finnish drug delivery technology and drug development company DelSiTech Ltd welcomes Dr. Hanna Arstila, as the new Director, Head of Formulation Development. The new position took effect in October 2020.

Dr. Hanna Arstila has her scientific background in biomaterial research and development. She has a PhD in Inorganic Chemistry from Åbo Akademi University. Prior to joining DelSiTech she has worked over ten years in several positions in Orion Pharma ranging from industrialization, product lifecycle management to managing production operations. With strong GMP and LEAN Six Sigma leadership knowledge she brings new, fresh insight to the company and its rapid growth in high quality product development.

“I am looking forward to new challenges in a variety of interesting projects. I’m impressed by the work done so far in DelSiTech, both in in-house projects as well as with external partners.” said Hanna.

Lasse Leino, CEO of DelSiTech expressed his satisfaction upon completion of this latest Director level recruitment saying: “Hanna brings with her valuable know-how in manufacturing operations and quality systems that are essential for the company’s business growth strategy. In addition, she has solid leadership experience in pharma industry that will complement our highly talented formulation development team.”